FLUPIRTINE IN THE THERAPY OF CHRONIC LOW BACK PAIN SYNDROMES
- Authors: Vyshlova I.1, Karpov S.1, Baida A.1
-
Affiliations:
- Stavropol State Medical University
- Issue: Vol 28, No 10 (2017)
- Pages: 68-69
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117097
- ID: 117097
Cite item
Abstract
The use of flupirtine in chronic low back pain contributed to less pain intensity with a significant decrease in the levels of anxiety and depression and with better quality of life in patients.
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
I. Vyshlova
Stavropol State Medical University
S. Karpov
Stavropol State Medical University
Email: Karpov25@rambler.ru
A. Baida
Stavropol State Medical University
References
- Vyshlova I., Azoidis I., Karpov S. Epidemiology of vertebrogenic pain syndromes P12089 // Eur. J. Neurol. - 2016; 23 (S2): 293.
- Вышлова И.А., Карпов С.М., Стародубцев А.И. Вертеброгенные болевые синдромы поясничного уровня: эпидемиология, клинические проявления // Мед. вестн. Северного Кавказа. - 2016; 11 (4): 586-8.
- Вышлова И.А., Карпов С.М. Причины и исходы хронического болевого синдрома в нижней части спины // Анестезиол. и реаниматол. - 2016; 61 (5S): 48.
- Вышлова И.А. Комплексное лечение больных с хроническими вертебро-генными болевыми синдромами // Кубанский научн. мед. вестник. - 2012; 2: 47-9.
- Хроническая боль в спине. Клинические рекомендации. Под ред. И.Н. Денисова / М., СПб, Ростов-на-Дону, 2014; 20 с.
- Uberall M., Essner U., Müller-Schwefe G. 2-week efficacy and tolerability of flupirtine MR and diclofenac in patients with acute low/back pain--results of a post-hoc subgroup analysis of patient-level data from four non-interventional studies // MMW Fortschr. Med. - 2013; 155 (Suppl. 4): 115-23. German.
- Uberall M., Mueller-Schwefe G., Terhaag B. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study // Curr. Med. Res. Opin. - 2012; 28 (10): 1617-34. doi: 10.1185/03007995.2012.726216.
- Pavlenko S., Veretel'nikov I., Fomin G. et al. The use of katadolon (flupirtine) in the treatment of lower back pain // Zh. Nevrol. Psikhiatr. im. S.S. Korsakova. -2006; 106 (4): 70-1.
- Müller-Schwefe G., Uberall M. Analgesic and muscle tonus normalizing effect of flupirtine retard in chronic back pain // MMW Fortschr. Med. - 2007; 149 (43): 47.
- Li C., Ni J., Wang Z. et al. Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial // Curr. Med. Res. Opin. - 2008; 24 (12): 3523-30. doi: 10.1185/03007990802579769.
Supplementary files
![](/img/style/loading.gif)